Systems Biology Approach for Cancer Vaccine Development and Evaluation

Vaccines

Luisa Circelli²  Annacarmen Petrizzo²  Maria Tagliamonte²  Maria Lina Tornesello²  Franco M. Buonaguro²  Luigi Buonaguro¹ 

[1] Laboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale” - IRCCS, Naples 80131, Italy;

关键词: systems vaccinology;    cancer vaccine;    cancer immunotherapy;   

DOI  :  10.3390/vaccines3030544

来源: mdpi

【 摘 要 】

Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy. The newly developed high throughput technologies and computational tools are instrumental to this aim allowing the identification of more specific antigens and the comprehensive analysis of the innate and adaptive immunities. Here, we review the potentiality of systems biology in providing novel insights in the mechanisms of the action of vaccines to improve their design and effectiveness.

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.